MEDICAMEN BIOTECH
Back to Income Statement
|
MEDICAMEN BIOTECH Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹9.49 Cr | ₹15 Cr | ₹15 Cr | ₹1,212,944 Cr | ₹13 Cr |
What is the latest Consolidated Net Profit of MEDICAMEN BIOTECH ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹9.49 Cr |
| Mar2024 | ₹15 Cr |
| Mar2023 | ₹15 Cr |
| Mar2022 | ₹1,212,944 Cr |
| Mar2021 | ₹13 Cr |
How is Consolidated Net Profit of MEDICAMEN BIOTECH Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹9.49 Cr | -35.54 | |
| Mar2024 | ₹15 Cr | -1.13 | |
| Mar2023 | ₹15 Cr | -100.00 | |
| Mar2022 | ₹1,212,944 Cr | 9,125,955.15 | |
| Mar2021 | ₹13 Cr | - | |
Compare Consolidated Net Profit of peers of MEDICAMEN BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MEDICAMEN BIOTECH | ₹363.7 Cr | -2.7% | 7.6% | -35.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,121.0 Cr | 3.2% | 12.5% | 10.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,396.0 Cr | 2.9% | 8.5% | 11.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,730.0 Cr | 0.3% | 5.7% | 36.3% | Stock Analytics | |
| CIPLA | ₹115,241.0 Cr | 10.4% | 15.9% | -5.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,126.0 Cr | 4.8% | 9% | 10.8% | Stock Analytics | |
MEDICAMEN BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MEDICAMEN BIOTECH | -2.7% |
7.6% |
-35.8% |
| SENSEX | -0.9% |
-3.6% |
-8.6% |
You may also like the below Video Courses